South Korea's Celltrion says COVID-19 drug shows 100-fold reduction in viral load

South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.

from Reuters: Health News https://ift.tt/36N7fmZ
via IFTTT